262 related articles for article (PubMed ID: 27692115)
21. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
22. Dyslipidemia in the metabolic syndrome in children.
Gidding SS
J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of the metabolic syndrome among obese adolescents enrolled in a multidisciplinary weight management program: clinical correlates and response to treatment.
Wickham EP; Stern M; Evans RK; Bryan DL; Moskowitz WB; Clore JN; Laver JH
Metab Syndr Relat Disord; 2009 Jun; 7(3):179-86. PubMed ID: 19450141
[TBL] [Abstract][Full Text] [Related]
24. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
[TBL] [Abstract][Full Text] [Related]
25. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome and heart failure--the risk, paradox, and treatment.
Gaddam KK; Ventura HO; Lavie CJ
Curr Hypertens Rep; 2011 Apr; 13(2):142-8. PubMed ID: 21298579
[TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
Florez H; Temprosa MG; Orchard TJ; Mather KJ; Marcovina SM; Barrett-Connor E; Horton E; Saudek C; Pi-Sunyer XF; Ratner RE; Goldberg RB;
Diabetes Obes Metab; 2014 Apr; 16(4):326-33. PubMed ID: 24118860
[TBL] [Abstract][Full Text] [Related]
28. Effects of weight reduction therapy on obstructive sleep apnea syndrome and arterial stiffness in patients with obesity and metabolic syndrome.
Iguchi A; Yamakage H; Tochiya M; Muranaka K; Sasaki Y; Kono S; Shimatsu A; Satoh-Asahara N
J Atheroscler Thromb; 2013; 20(11):807-20. PubMed ID: 23883546
[TBL] [Abstract][Full Text] [Related]
29. Exercise training workloads in cardiac rehabilitation are associated with clinical outcomes in patients with heart failure.
Keteyian SJ; Kerrigan DJ; Lewis B; Ehrman JK; Brawner CA
Am Heart J; 2018 Oct; 204():76-82. PubMed ID: 30081276
[TBL] [Abstract][Full Text] [Related]
30. Influence of a hybrid form of cardiac rehabilitation on exercise tolerance in coronary artery disease patients with and without diabetes.
Szalewska D; Tomaszewski J; Kusiak-Kaczmarek M; Niedoszytko P; Gierat-Haponiuk K; Haponiuk I; Bakuła S
Kardiol Pol; 2015; 73(9):753-60. PubMed ID: 25985731
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of the insulin resistance syndrome.
Meigs JB
Curr Diab Rep; 2003 Feb; 3(1):73-9. PubMed ID: 12643149
[TBL] [Abstract][Full Text] [Related]
32. The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data.
Dunkley AJ; Davies MJ; Stone MA; Taub NA; Troughton J; Yates T; Khunti K
Trials; 2011 May; 12():107. PubMed ID: 21542913
[TBL] [Abstract][Full Text] [Related]
33. Nut Consumptions as a Marker of Higher Diet Quality in a Mediterranean Population at High Cardiovascular Risk.
Bibiloni MDM; Julibert A; Bouzas C; Martínez-González MA; Corella D; Salas-Salvadó J; Zomeño MD; Vioque J; Romaguera D; Martínez JA; Wärnberg J; López-Miranda J; Estruch R; Bueno-Cavanillas A; Arós F; Tinahones F; Serra-Majem L; Martín V; Lapetra J; Vázquez C; Pintó X; Vidal J; Daimiel L; Delgado-Rodríguez M; Matía P; Ros E; Fernández-Carrión R; Garcia-Rios A; Zulet MA; Orozco-Beltrán D; Schröder H; Fitó M; Bulló M; Basora J; Cenoz JC; Diez-Espino J; Toledo E; Tur JA
Nutrients; 2019 Mar; 11(4):. PubMed ID: 30935087
[TBL] [Abstract][Full Text] [Related]
34. Total and Subtypes of Dietary Fat Intake and Its Association with Components of the Metabolic Syndrome in a Mediterranean Population at High Cardiovascular Risk.
Julibert A; Bibiloni MDM; Bouzas C; Martínez-González MÁ; Salas-Salvadó J; Corella D; Zomeño MD; Romaguera D; Vioque J; Alonso-Gómez ÁM; Wärnberg J; Martínez JA; Serra-Majem L; Estruch R; Tinahones FJ; Lapetra J; Pintó X; Lopez-Miranda J; García-Molina L; Gaforio JJ; Matía-Martín P; Daimiel L; Martín-Sánchez V; Vidal J; Vázquez C; Ros E; Toledo E; Becerra-Tomás N; Pórtoles O; Pérez-Vega KA; Fiol M; Torres-Collado L; Tojal-Sierra L; Carabaño-Moral R; Abete I; Sanchez-Villegas A; Casas R; Bernal-López MR; Santos-Lozano JM; Galera A; Ugarriza L; Ruiz-Canela M; Babio N; Coltell O; Schröder H; Konieczna J; Orozco-Beltrán D; Sorto-Sánchez C; Eguaras S; Barrubés L; Fitó M; Tur JA;
Nutrients; 2019 Jun; 11(7):. PubMed ID: 31261967
[No Abstract] [Full Text] [Related]
35. Effects of Avena nuda L. on metabolic control and cardiovascular disease risk among Chinese patients with diabetes and meeting metabolic syndrome criteria: secondary analysis of a randomized clinical trial.
Ma X; Gu J; Zhang Z; Jing L; Xu M; Dai X; Jiang Y; Li Y; Bao L; Cai X; Ding Y; Wang J; Li Y; Li Y
Eur J Clin Nutr; 2013 Dec; 67(12):1291-7. PubMed ID: 24129363
[TBL] [Abstract][Full Text] [Related]
36. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
Deedwania P; Barter P; Carmena R; Fruchart JC; Grundy SM; Haffner S; Kastelein JJ; LaRosa JC; Schachner H; Shepherd J; Waters DD;
Lancet; 2006 Sep; 368(9539):919-28. PubMed ID: 16962881
[TBL] [Abstract][Full Text] [Related]
37. Adipokines demonstrate the interacting influence of central obesity with other cardiometabolic risk factors of metabolic syndrome in Hong Kong Chinese adults.
Supriya R; Tam BT; Yu AP; Lee PH; Lai CW; Cheng KK; Yau SY; Chan LW; Yung BY; Sheridan S; Siu PM
PLoS One; 2018; 13(8):e0201585. PubMed ID: 30114249
[TBL] [Abstract][Full Text] [Related]
38. Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation.
Gitt A; Jannowitz C; Karoff M; Karmann B; Horack M; Völler H
Vasc Health Risk Manag; 2012; 8():265-74. PubMed ID: 22566748
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome, clustering of cardiovascular risk factors and high carotid intima-media thickness in children and adolescents.
Zhao M; Caserta CA; Medeiros CCM; López-Bermejo A; Kollias A; Zhang Q; Pacifico L; Reinehr T; Litwin M; Bassols J; Romeo EL; Ramos TDA; Stergiou GS; Yang L; Xargay-Torrent S; Amante A; Estrela TM; Grammatikos E; Zhang Y; Prats-Puig A; Franklin de Carvalho D; Yang L; Carreras-Badosa G; de Oliveira Simões M; Hou Y; Lizarraga-Mollinedo E; Shui W; Guo T; Wang M; Zhang Y; Bovet P; Xi B;
J Hypertens; 2020 Apr; 38(4):618-624. PubMed ID: 31790055
[TBL] [Abstract][Full Text] [Related]
40. Diabetes mellitus: a cardiovascular disease.
Candido R; Srivastava P; Cooper ME; Burrell LM
Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
